Company news
Weihai Baihe Biology Technological Co., Ltd. news in 2025
Weihai Baihe Biology Technological Co., Ltd.'s news releases, calls and decks from 2025, newest first.
Announcement on Re-signing Tripartite Supervision Agreement over Deposit in Special Account of Raised Funds
December 11, 2025
Announcement on Convening the Q3 2025 Performance Briefing
December 3, 2025
Announcement on Postponing Some Investment Projects Financed by Raised Funds
December 1, 2025
Report for Q3 2025
October 29, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
September 26, 2025
2025 Semi-annual Report
August 29, 2025
Announcement on Completion of Transfer of Acquired Overseas Company Equity
August 25, 2025
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
August 11, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 29, 2025
Announcement on Adjusting the Total Profit Distribution in 2024
July 18, 2025
Announcement on Results of Shareholding Reduction by Director
July 16, 2025
Announcement on Share Repurchase Reaching 1%, Implementation Result of Shares Repurchase and Share Changes
July 15, 2025
Announcement on Adjusting Price Ceiling for Share Repurchase
July 14, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
July 1, 2025
Announcement on Resolution of the 2024 Annual General Meeting
June 6, 2025
Announcement on Convening the 2024 Annual Performance Briefing
June 3, 2025
Announcement on Share Reduction Plan for Directors
May 21, 2025
Announcement on Abnormal Fluctuations in Stock Trading
May 19, 2025
2024 Annual Report
April 14, 2025
Announcement on Initially Repurchasing Shares through Call Auction
March 10, 2025
Announcement on Change of Signatory Certified Public Accountant and Project Quality Control Reviewer
March 7, 2025
Announcement on Failure to Implement Repurchase with Half of the Repurchase Period Expired
February 10, 2025
Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public Offering
January 20, 2025